Benidipine
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | |
Identifiers | |
| |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C28H31N3O6 |
Molar mass | 505.57 g·mol−1 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Sheng Shi, M.D. [2]
Benidipine (INN), also known as Benidipinum or benidipine hydrochloride, is a dihydropyridine calcium channel blocker for the treatment of high blood pressure (hypertension).
Dosing
Benidipine is dosed as 2–4 mg once daily.[1]
Availability
Benidipine is sold as Coniel by Kyowa Hakko Kogyo.
Benidipine is only licensed for use in Japan and selected Southeast Asian countries, where it is sold as 4 mg tablets.
References
- ↑ Hi-Eisai Pharmaceutical, Inc. "Coniel (benidipine) package insert (Philippines)". MIMS Philippines. CMPMedica. Retrieved 2008-03-31.
Categories:
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Calcium channel blockers
- Dihydropyridines
- Piperidines
- Carboxylate esters
- Nitrobenzenes
- Methyl esters
- Selective calcium channel blockers with mainly vascular effects
- Dihydropyridine derivatives
- Cardiovascular Drugs
- Drug